They found that BVC not only enhances the immune recognition between CD8 + T cells and FAS-overexpressing tumor cells but also reduces tumor cell immune escape through PD-1/PD-L1 blockade, resulting in significant benefits for the eradication of metastatic tumors [171]. Here, CD8A is linked to neoplasm.